Nestmedic S.A. (WSE:NST)
Poland
· Delayed Price · Currency is PLN 0.675
0.00 (0.00%)
At close: Dec 4, 2025
Nestmedic Revenue
Nestmedic had revenue of 159.75K PLN in the quarter ending September 30, 2025, a decrease of -6.57%. This brings the company's revenue in the last twelve months to 1.05M, up 57.33% year-over-year. In the year 2024, Nestmedic had annual revenue of 969.20K, down -37.39%.
Revenue (ttm)
1.05M
Revenue Growth
+57.33%
P/S Ratio
27.62
Revenue / Employee
351.21K
Employees
4
Market Cap
29.10M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 969.20K | -578.88K | -37.39% |
| Dec 31, 2023 | 1.55M | -318.97K | -17.08% |
| Dec 31, 2022 | 1.87M | 1.21M | 185.24% |
| Dec 31, 2021 | 654.56K | 283.58K | 76.44% |
| Dec 31, 2020 | 370.99K | -37.16K | -9.11% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Diagnostyka | 2.30B |
| NEUCA | 13.34B |
| Synektik Spólka Akcyjna | 623.20M |
| Voxel | 568.83M |
| Celon Pharma | 225.60M |
| Selvita | 373.90M |
| Ryvu Therapeutics | 90.41M |
| Centrum Medyczne ENEL-MED | 820.59M |